pI: 9.067 |
Length (AA): 411 |
MW (Da): 47178 |
Paralog Number:
2
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 7
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_191926)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_00305 | protein F46F5.4 |
Caenorhabditis elegans | CELE_F25H2.7 | Protein F25H2.7 |
Loa Loa (eye worm) | LOAG_10353 | hypothetical protein |
Loa Loa (eye worm) | LOAG_13829 | hypothetical protein |
Loa Loa (eye worm) | LOAG_07922 | hypothetical protein |
Onchocerca volvulus | OVOC11794 |
|
Onchocerca volvulus | OVOC11795 |
|
Onchocerca volvulus | OVOC170 |
|
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Rattus norvegicus | Somatostatin receptor 2 | 369 aa | 24.1% | 402 aa | Compounds | References |
Rattus norvegicus | Neuropeptide Y receptor type 1 | 382 aa | 21.7% | 378 aa | Compounds | References |
Cavia porcellus | Type-1 angiotensin II receptor | 359 aa | 20.6% | 291 aa | Compounds | References |
Rattus norvegicus | Nociceptin receptor | 367 aa | 24.7% | 352 aa | Compounds | References |
Rattus norvegicus | Somatostatin receptor | 363 aa | 25.1% | 331 aa | Compounds | References |
Sus scrofa | Type-1 angiotensin II receptor | 359 aa | 20.2% | 321 aa | Compounds | References |
Cavia porcellus | Nociceptin receptor | 370 aa | 23.7% | 338 aa | Compounds | References |
Rattus norvegicus | Kappa opioid receptor | 380 aa | 20.8% | 313 aa | Compounds | References |
Danio rerio | Mu opioid receptor-like OR2 | 384 aa | 22.5% | 315 aa | Compounds | References |
Rattus norvegicus | Somatostatin receptor 5 | 363 aa | 25.1% | 331 aa | Compounds | References |
Rattus norvegicus | Galanin receptor 2 | 372 aa | 21.2% | 306 aa | Compounds | References |